NYSE:BIO - New York Stock Exchange, Inc. - US0905722072 - Common Stock - Currency: USD
2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
---|---|---|---|---|---|---|---|---|
Revenue | 2.57B | 2.67B | 2.80B | 2.92B | 2.55B | |||
Minority Interest Expense | N/A | N/A | N/A | N/A | N/A | |||
Cost Of Goods | 1.19B | 1.24B | 1.23B | 1.26B | 1.11B | |||
Gross Profit | 1.38B | 1.43B | 1.57B | 1.66B | 1.44B | |||
Operating Expenses | 1.08B | 1.07B | 1.08B | 1.10B | 1.02B | |||
Research and Development | 266.40M | 240.93M | 256.80M | 247.30M | 217.80M | |||
Selling, General, and Administrative Expenses | 814.00M | 824.22M | 824.80M | 851.00M | 798.80M | |||
Operating Income | 298.50M | 365.70M | 486.80M | 564.70M | 421.30M | |||
Interest Income/Expense | -2.61B | -1.19B | -5.17B | 4.95B | 4.49B | |||
Other Income/Expense | 1.60M | 4.84M | -2.40M | 700.00K | -1.80M | |||
Non Recurring Items | -29.50M | -27.90M | -17.50M | -65.20M | 7.10M | |||
Income Before Taxes | -2.34B | -850.10M | -4.70B | 5.45B | 4.92B | |||
Income Tax | -498.30M | -212.78M | -1.08B | 1.19B | 1.10B | |||
Net Income | -1.84B | -637.32M | -3.63B | 4.25B | 3.81B | |||
Per Share Data | ||||||||
EPS Diluted Total Ops | -65.36 | -21.82 | -121.72 | 140.87 | 126.29 | |||
Non GAAP EPS | 10.31 | 11.77 | 14.23 | 15.67 | 10.53 | |||
Statistics | ||||||||
Gross Profit Margin | 53.73% | 53.56% | 55.97% | 56.91% | 56.49% | |||
Profit Margin | -71.86% | -23.86% | -129.45% | 145.57% | 149.84% | |||
Operating Profit Margin | 11.63% | 13.69% | 17.37% | 19.32% | 16.55% |
All data in USD